Related Experiment Video
Updated: May 28, 2026

A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
Published on: October 20, 2010
In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?
Susanne Perkhofer1, Cornelia Mrazek, Lukas Hartl
1Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Fritz Pregl Strasse 3, 6020, Innsbruck, Austria, susanne.perkhofer@i-med.ac.at.
Abstract:
An increasing number of patients are undergoing transplantation procedures or receiving aggressive immunosuppression and chemotherapy. The growing population of immunocompromised hosts has led to a rise in the prevalence of invasive fungal infections due to yeasts and molds. The introduction of new antifungal agents and recent reports of resistance emerging during treatment of fungal infections have highlighted the need for in vitro susceptibility testing. Various testing procedures have been proposed, including macrodilution and microdilution, agar diffusion, disk diffusion, and Etest (AB Biodisk, Solna, Sweden). Establishing clinical correlation with antifungal susceptibility testing, however, is a huge challenge because susceptibility techniques do not take into account the dynamic and complex biology of fungi exposed to an antifungal in vivo. This paper reviews the available methods for antifungal susceptibility testing of yeasts and filamentous fungi and the data regarding the clinical implications of in vitro testing.
Insights
In vitro antifungal susceptibility testing is crucial for managing invasive fungal infections in immunocompromised patients. However, correlating these tests with clinical outcomes remains challenging due to complex fungal biology.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Increasing prevalence of invasive fungal infections in immunocompromised patients undergoing transplantation, chemotherapy, or immunosuppression.
- Emergence of antifungal resistance necessitates reliable susceptibility testing methods.
- Growing population of immunocompromised hosts worldwide.
Purpose of the Study:
- To review available in vitro antifungal susceptibility testing methods for yeasts and filamentous fungi.
- To discuss the clinical implications and challenges of interpreting antifungal susceptibility test results.
- To highlight the need for better correlation between in vitro data and in vivo outcomes.
Main Methods:
- Review of established antifungal susceptibility testing procedures including macrodilution, microdilution, agar diffusion, disk diffusion, and Etest.
- Analysis of existing data on clinical correlations of in vitro antifungal susceptibility testing.
- Examination of the limitations of current susceptibility techniques in reflecting in vivo fungal biology.
Main Results:
- Multiple in vitro methods exist for assessing antifungal susceptibility in fungi.
- Clinical correlation of susceptibility testing remains a significant challenge.
- Current in vitro methods do not fully capture the complex interactions between antifungals and fungi in vivo.
Conclusions:
- In vitro antifungal susceptibility testing is essential for guiding treatment of invasive fungal infections.
- Further research is needed to improve the clinical relevance of antifungal susceptibility testing.
- Understanding the limitations of current methods is key to optimizing antifungal therapy in immunocompromised patients.
Related Concept Videos
In Vitro Drug Release Testing: Overview, Development and Validation
Clinically Relevant Drug Product Specifications: Methods of Establishment
Urine Studies II: Urine Culture and Sensitivity Test
Antimicrobial Effectiveness
Rapid Identification of Pathogens
Automated Microbial Diagnostics

